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Abstract 
Objective: Tuberculosis (TB), an infectious disease caused by the bacillus Mycobacterium tuberculosis (MTB), is a 
global health problem. Because the failing immune response in the lung can lead to formation of a pulmonary cavity, 
this study was designed to clarify MTB-specific lymphocyte responses in TB patients with pulmonary cavities.
Methods: We utilized culture filtrate protein 10 (CFP-10) and early secretory antigenic target 6 (ESAT-6) as immuno-
genic MTB antigens following overnight stimulation of peripheral blood mononuclear cells (PBMCs). By flow cytom-
etry, we then dissected CD4+ and CD8+ T lymphocytes secreting intracellular cytokines of IFN-γ and TNF-α to assess 
the local immune response of TB patients with pulmonary cavities compared with those having other radiological 
infiltrates.
Results: As expected, after 16 h of ex vivo activation using both ESAT-6 and CFP-10, the proportions of CD4+IFN-γ, 
CD4+TNF-α, CD8+TNF-α, and CD8+IFN-γ cells were all markedly increased in 46 patients with TB when compared 
with 23 household contacts. However, the IFN-γ and TNF-α responses of both CD4+ and CD8+ T lymphocytes were 
found to be relatively lower in 18 patients who had pulmonary cavities when compared with 28 patients who had 
radiological infiltrates. Moreover, patients with cavities had higher absolute numbers of neutrophils than patients with 
infiltrates. Further analysis indicated an inverse correlation between neutrophil counts and the proportions of IFN-γ-
secreting T cells.
Conclusion: MTB-specific lymphocyte responses are impaired in TB patients with pulmonary cavities that are likely to 
play an important role in the pathogenesis of cavitary TB.
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Background
Tuberculosis (TB), an infectious disease caused by the 
bacillus Mycobacterium tuberculosis (MTB), is a global 
health problem. Overall, a relatively small proportion 
(5–15%) of the estimated 2–3 billion people infected 
with MTB will develop TB disease during their lifetimes 
[1]. However, the probability of developing TB is much 
higher among people infected with human immunodefi-
ciency virus (HIV), indicating that the adaptive immune 
response plays a vital role in controlling MTB pathogen-
esis. The components of this protective immune response 
have been investigated with an emphasis on the role of 
T cells secreting type-1 cytokines, specifically TNF-α and 
IFN-γ, in the formation of granulomas in the lung [2–6].
However, a failing immune response in the lung may 
be involved in the formation of pulmonary cavities. With 
regard to the TNF-α and IFN-γ responses of cavitary TB, 
several investigators have produced conflicting results. 
Casarini noted only that IFN-γ but not TNF-α was 
reduced in cavities compared with areas of infiltrates as 
measured by ELISA [4], and Condos demonstrated simi-
lar results [5]. However, Mazzarella pointed to a reduc-
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infiltrates [6]. Fan et  al. also recently demonstrated that 
the MTB antigen-specific Th1 response was decreased 
when pulmonary TB (PTB) lesions developed in severe 
cavities [7].
T cells specific for multiple immunogenic antigens of 
MTB have recently been identified, including the Ag85 
complex, culture filtrate protein 10 (CFP-10), early secre-
tory antigenic target 6 (ESAT-6), heat shock protein 65, 
and TB10.4 [8–11]. In particular, ESAT-6 and CFP-10 
have been utilized as antigens for the immune diagnosis 
of MTB infection based on the presence of IFN-secreting 
cells; both have been shown to be more specific and sen-
sitive than tuberculin skin tests [12].
Flow cytometry (FCM) is a powerful technology for 
characterizing each cell in terms of both the intracellu-
lar cytokines, and also activation markers. In addition, 
FCM is better than enzyme-linked immunosorbent assay 
(ELISA) to detect cytokines in peripheral blood mono-
nuclear cells (PBMCs) from patients with TB, because 
ELISA cannot reveal which specific cells are producing 
and secreting the measured cytokines.
To clarify MTB-specific lymphocyte responses in TB 
patients with pulmonary cavities, we utilized ESAT-6 and 
CFP-10 as immunogenic antigens and FCM to determine 
the blood lymphocyte responses of CD4+ and CD8+ T 
lymphocytes producing and secreting IFN-γ and TNF-α 
in order to study the local immune responses of subjects 
with cavitary disease as compared to individuals having 
pulmonary infiltrates.
Methods
Study subjects and ethics statement
Our study included 46 newly diagnosed patients with 
PTB and 23 household contacts from the physical exami-
nation center of our hospital with both TST and T-SPOT 
negative. All information on the patients was recorded 
in the clinical database of the Infectious Disease Hospi-
tal of Wuxi, China. PBMCs were isolated before treat-
ment from blood samples by means of centrifugation 
with Ficoll-Hypaque (Sigma). PTB was diagnosed when 
subjects with clinical and/or imaging features compatible 
with TB met at least one of the following criteria: posi-
tive sputum smear for acid-fast bacilli; positive culture 
for MTB, biopsy suggestive of TB, and/or full response to 
anti-TB treatment. A radiologist reviewed the posteroan-
terior chest radiographs (CXRs) of all 48 newly diagnosed 
PTB patients for the presence or absence of cavities. A 
respiratory clinician reviewed all CXRs at the same time, 
with both agreeing on the results.
Synthetic peptides
Peptides (16- to 18-mers overlapping by 10 aa) corre-
sponding to the sequence of the MTB antigens CFP-10 
and ESAT-6 were synthesized on an automated peptide 
synthesizer. For initial screening purposes, peptides were 
arranged into pools of 9 peptides each in matrix fashion, 
such that each peptide was uniquely represented in 2 
pools [13].
Intracellular cytokine staining and immunophenotyping
PBMCs were isolated from heparin anticoagulant whole 
blood and incubated with stimulated antigens using 
200 μL of per stimulation in a polypropylene tube. Each 
patient had four different stimulation setups: negative 
(medium alone), positive [Phorbol 12-myristate 13-ace-
tate (PMA), each at 5 mg/mL], CFP-10 (10 mg/mL), and 
ESAT-6 (10 mg/mL). Tubes were vortexed, covered, and 
kept overnight (16 h) at 37 °C in a 5% CO2 incubator. In 
addition, 10 μg of Brefeldin A (Sigma) was added after 2 h 
of incubation. Following overnight stimulation, the cells 
were washed and stained with the following surface anti-
bodies at room temperature for 15 min: energy-coupled 
dye (ECD)-conjugated anti-CD3 and fluorescein iso-
thiocyanate (FITC)-conjugated anti-CD8. The cells were 
washed, fixed, and permeabilized (with Caltag reagents A 
and B) (Caltag Laboratories). The following intracellular 
antibodies were then added: phycoerythrin–Cy5.5 (PE-
Cy5.5)-conjugated anti-IFN-γ and phycoerythrin (PE)-
conjugated TNF-α. All antibodies were purchased from 
Becton–Dickinson.
The cells were incubated for 15 min and then washed 
and placed on an FC500 (Beckman Coulter) flow cytom-
eter. Negative controls consisting of PBMCs incu-
bated with medium alone were included in each assay. 
Responses  ≥0.03% above the background value were 
considered to be positive. For phenotypic analysis of 
CD8 cells, peptide-stimulated cells were gated on CD3+/
CD8+  cells and analyzed for expression of TNF-α and 
IFN-γ. For phenotypic analysis of CD4 cells, peptide-
stimulated cells were gated on CD3+/CD8−  cells and 
analyzed for expression of TNF-α and IFN-γ.
Statistical methods
Statistical analyses were conducted using GraphPad 
Prism software version 4.0. The unpaired, nonparametric 
t test (Mann–Whitney test), Chi square test, and Spear-
man rank correlation analysis were performed. Values of 
P < 0.05 were considered to be statistically significant for 
all analyses.
Results
Characteristics of the study population
Our subjects included 46 newly treated TB patients, 
including 18 patients with cavitary TB, and 28 patients 
who presented with chest infiltrates on CT scanning. 
Among the 23 household contacts, there were 11 males 
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and 12 females whose mean age was 50.1 ± 5.6 years. The 
clinical characteristics of the 46  TB patients and their 
laboratory data are summarized in Table  1. No signifi-
cant differences were found regarding age, gender, abso-
lute number of white blood cells (WBCs), monocytes and 
lymphocytes, or the proportions of CD3+, CD3+/CD4, 
and CD3+/CD8+ lymphocytes between 18 patients 
with chest cavities and 28 patients with infiltrates. How-
ever, there were significant differences with regard to the 
absolute number of neutrophils. Patients with cavities 
had higher absolute neutrophil counts than patients with 
infiltrates.
Increased percentages of MTB antigen‑specific 
cytokine‑producing T cells in TB patients
We stained cells for identification by FCM and then 
tested the proportions of IFN-γ- and TNF-α-producing 
CD4+  and CD8+  T cells after cells were cultured and 
stimulated with ESAT-6 and CFP-10, respectively. Results 
are presented in Table 2. As expected, the percentages of 
IFN-γ and TNF-α produced by CD4+ and CD8+ T cells 
after stimulation with ESAT-6 and CFP-10 were signifi-
cantly higher in TB patients than in household contacts 
(P values all <0.05).
Impaired MTB antigen‑specific responses of CD4+ and 
CD8+ T lymphocytes in PTB patients with cavities
MTB-specific responses of CD4+  and CD8+  T lym-
phocytes from TB patients measured by intracellular 
TNF-α and IFN-γ staining after overnight incubation 
were shown as FCM dot plots (Fig.  1a, b). TB patients 
were divided into two groups; on computed tomography 
(CT) of the chest, 18 patients presented with cavities 
and the 28 others with infiltrates. The result showed that 
the TNF-α and IFN-γ produced by CD4+ and CD8+ T 
lymphocytes in response to ESAT-6 and CFP-10 in the 
patients with cavities were statistically reduced com-
pared with the radiological infiltrates (P values all <0.05) 
(Fig. 1c, d). The data on the TB patients with cavities and 
the household contacts were equally low, with P  >  0.05 
(not shown).
Inverse correlation between the proportions 
of MTB‑specific IFN‑γ‑secreting T cells and neutrophil 
counts
To further determine the impact of high absolute neutro-
phil counts in patients with cavities on the impaired MTB 
antigen-specific responses, we analyzed the relationship 
between the proportions of MTB antigen-specific IFN-
γ- and TNF-α-secreting T cells (CD4+ and CD8+) with 
neutrophil counts in all TB patients and found no cor-
relation between TNF-α-secreting T cells with neutro-
phil counts (Fig. 2a, c). However, both IFN-γ-producing 
CD4+  and CD8+  T cells had significant inverse corre-
lations with neutrophil counts (R = −0.2809, P = 0.007; 
R = −0.2098, P = 0.0447, respectively) (Fig. 2b, d).
Discussion
Type-1 immune dominance during TB was shown by the 
predominance of CD4+  and CD8+  T cells responsive 
to MTB antigens by rapid IFN-γ and TNF-α synthesis. 
These cells were found in both radiologically involved 
and uninvolved pulmonary sites but were conspicuously 
Table 1 Characteristics of 46 TB patients
a By Mann–Whitney or Pearson’s Chi square test
b Data are presented as numbers (%) of individuals except indicated
c Data are presented as median numbers (interquartile range)
Characteristic TB cases (n = 46)
Cavity (n = 18) Infiltrates (n = 28) P valuea
Age (years) 55.5 45 0.175
No. % of male sub-
jectsb
13 (72.2) 18 (64.3) 0.390
Cell count (109/L)c
 WBC 6.54 (5.89–8.04) 5.49 (4.76–7.13) 0.105
 Monocytes 0.53 (0.37–0.71) 0.39 (0.32–0.61) 0.131
 Lymphocytes 1.38 (1.14–1.56) 1.26 (1.02–2.02) 0.831
 Neutrophils 4.48 (4.04–5.76) 3.85 (2.56–5.27) 0.019
No. % of positive cellsb
CD3+ 60.6 (44.3–67.0) 55.6 (52.2–65.4) 0.288
CD3+/CD4+ 39.3 (31.1–41.4) 35.4 (29.4–45.5) 0.575
CD3+/CD8+ 26.3 (22.5–31.6) 21.9 (16.5–31.8) 0.334
Table 2 TB patients have significantly higher proportions 
of IFN-γ- and TNF-α-producing T cells
By Mann–Whitney, NTB non-tuberculosis, TB tuberculosis, HCs household 
contacts
TB (n = 46) HCs (n = 23) P valueb
ESAT-6
 CD4
  TNF-α 2.40 (1.90–3.83) 1.71 (1.50–2.40) 0.0003
  IFN-γ 0.30 (0.20–0.70) 0.20 (0.13–0.22) 0.0009
 CD8
  TNF-α 3.30 (2.20–4.23) 1.71 (1.35–2.50) <0.0001
  IFN-γ 0.65 (0.40–1.75) 0.27 (0.14–0.70) 0.0003
CP-10
 CD4
  TNF-α 2.35 (0.19–0.33) 1.99 (1.63–2.21) 0.0254
  IFN-γ 0.40 (0.20–0.63) 0.33 (0.24–0.43) 0.0017
 CD8
  TNF-α 2.95 (2.00–4.55) 2.10 (1.60–2.60) 0.0027
  IFN-γ 0.60 (0.15–0.52) 0.29 (0.15–0.52) 0.0166
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reduced in areas of cavity formation [14]. Our results 
indicate that proportions of TNF-α- and IFN-γ-
producing cells within both the CD4+  and CD8+  sub-
sets were significantly reduced in TB patients with 
cavities compared with those with radiological infiltrates 
after stimulation of ESAT-6 or CFP-10, respectively, 
although the activities of IFN-γ and TNF-α were broad 
and included both beneficial and detrimental effects 
[15]. IFN-γ and TNF-α may help to recruit cells to the 
site of infection and promote the antimicrobial activity 
of macrophages [16, 17]. In addition, TNF-α can lead to 
TNF-mediated apoptosis of infected macrophages, thus 
helping to eliminate the pathogen [14]. Therefore, type-1 
cytokines, IFN-γ and TNF-α, may generate protec-
tive granulomas and enhance the killing of MTB within 
macrophages.
(See figure on previous page.) 
Fig. 1 Flow cytometry dot plots of MTB-specific CD4+ and CD8+ T-lymphocyte responses in cavitary and infiltrative TB by intracellular TNF-α and 
IFN-γ staining. a Subject with predominant CD4 and CD8 response to EAST-6. b Subject with both CD4 and CD8 responses to CFP-10. The percent-
ages in the upper left quadrant denote the percentage of CD4+ TNF-α- or IFN-γ-positive cells; the right upper quadrant demonstrates the percent-
ages of CD8 lymphocytes producing TNF-α or IFN-γ cells. Plots of the compared pairs are from the same patient. c, d Nonparametric t-testing 
(Mann–Whitney test) was performed and P < 0.05 was considered to be a significant statistical difference
Fig. 2 The correlation between the proportion of MTB-specific TNF-α- and IFN-γ-secreting T cells (CD4+ and CD8+) and neutrophils counts. A 
Spearman rank correlation analysis was performed and P < 0.05 was considered to be a significant statistical difference
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However, the IFN-γ and TNF-α responses of both 
CD4+ and CD8+ T lymphocytes from TB patients were 
remarkably impaired in those individuals with pulmo-
nary cavities. The pulmonary cavity has been the classic 
hallmark of TB and is the site of a very high MTB burden. 
MTB infection triggers the recruitment of leukocytes and 
the activation of intercellular networks, which then results 
in tissue destruction [18]. Successful immune responses 
lead to the formation of granulomas and curtailment of 
the disease process, whereas cavitation indicates a fail-
ing immune response [19]. Histological examination also 
demonstrates a predominance of acid-fast bacilli only at 
the internal surfaces of the cavities, at which site there are 
few CD4 and CD8 lymphocytes [19]. The pulmonary cavi-
ties are the sites of high MTB burdens.
Cavitation has also been reported to be associated with 
local neutrophilia and relative lymphopenia [14]. Our 
results show that TB patients with cavities had higher 
absolute numbers of neutrophils than did patients with 
infiltrates; moreover, further analysis indicated an inverse 
correlation between the proportions of MTB-specific 
IFN-γ-secreting T cells and neutrophil counts. The accu-
mulation of neutrophils together with these impaired 
MTB-specific lymphocyte responses probably plays an 
important role in the pathogenesis of cavitary TB.
Our study also has limitations. The eligible patients rep-
resented a fraction of the patients diagnosed with active 
TB, raising a concern for a selection bias. The antigen of 
CD4 was endocytosed with the stimulation of PMA and 
also impaired by the process of permeabilization. There-
fore for the phenotypic analysis of CD4 cells, peptide-
stimulated cells were gated on CD3+ CD8− cells. Except 
for these limitations, we conclude that MTB-specific 
lymphocyte responses are impaired in TB patients with 
pulmonary cavities, which may explain the high MTB 
burden at the cavity site and the severity of cavitary.
Conclusions
MTB-specific lymphocyte responses are impaired in TB 
patients with pulmonary cavities that are likely to play an 
important role in the pathogenesis of cavitary TB.
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